42 related articles for article (PubMed ID: 18182280)
1. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
2. Effects of processing on the release profiles of matrix systems containing 5-aminosalicylic acid.
Korbely A; Kelemen A; Kása P; Pintye-Hódi K
AAPS PharmSciTech; 2012 Dec; 13(4):1341-7. PubMed ID: 23054987
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Evaluations of Berberine-Loaded Microparticles Filled In-House 3D Printed Hollow Capsular Device for Improved Oral Bioavailability.
Choudhury D; Jala A; Murty US; Borkar RM; Banerjee S
AAPS PharmSciTech; 2022 Mar; 23(4):89. PubMed ID: 35296955
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of MCC-SiO
Sangnim T; Zandu SK; Kaur S; Odeku OA; Huanbutta K; Singh I
Polymers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267857
[TBL] [Abstract][Full Text] [Related]
5. Design and
Hussain A; Misbah M; Abbas N; Irfan M; Arshad MS; Shamim R; Bukhari NI; Mahmood F
Turk J Pharm Sci; 2020 Oct; 17(5):486-491. PubMed ID: 33177928
[TBL] [Abstract][Full Text] [Related]
6. Nano and Microparticulate Chitosan Based System for Formulation of Carvedilol Rapid Melt Tablet.
Patil R; Pande V; Sonawane R
Adv Pharm Bull; 2015 Jun; 5(2):169-79. PubMed ID: 26236654
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.
Aljimaee YH; El-Helw AR; Ahmed OA; El-Say KM
Drug Des Devel Ther; 2015; 9():1379-92. PubMed ID: 25834396
[TBL] [Abstract][Full Text] [Related]
8. Development of Corn Starch-Neusilin UFL2 Conjugate as Tablet Superdisintegrant: Formulation and Evaluation of Fast Disintegrating Tablets.
Juneja P; Kaur B; Odeku OA; Singh I
J Drug Deliv; 2014; 2014():827035. PubMed ID: 25328710
[TBL] [Abstract][Full Text] [Related]
9. Oral Disintegration Tablets of Stavudine for HIV Management: A New Technological Approach.
Sankar V; Ramakrishna B; Devi PS; Karthik S
Indian J Pharm Sci; 2012 Nov; 74(6):556-63. PubMed ID: 23798782
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of carvedilol melt-in-mouth tablet using mucoadhesive polymer and PEG-6-stearate as hydrophilic waxy binder.
Dangi AA; Zalodiya PB
Int J Pharm Investig; 2012 Oct; 2(4):183-8. PubMed ID: 23580934
[TBL] [Abstract][Full Text] [Related]
11. Lallemantia reylenne seeds as superdisintegrant: Formulation and evaluation of nimesulide orodispersible tablets.
Malik K; Arora G; Singh I; Arora S
Int J Pharm Investig; 2011 Jul; 1(3):192-8. PubMed ID: 23071942
[TBL] [Abstract][Full Text] [Related]
12. Taste masked microspheres of ofloxacin: formulation and evaluation of orodispersible tablets.
Malik K; Arora G; Singh I
Sci Pharm; 2011; 79(3):653-72. PubMed ID: 21886910
[TBL] [Abstract][Full Text] [Related]
13. A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets.
Li FQ; Yan C; Bi J; Lv WL; Ji RR; Chen X; Su JC; Hu JH
Int J Nanomedicine; 2011; 6():897-904. PubMed ID: 21720502
[TBL] [Abstract][Full Text] [Related]
14. Phospholipids and lipid-based formulations in oral drug delivery.
Fricker G; Kromp T; Wendel A; Blume A; Zirkel J; Rebmann H; Setzer C; Quinkert RO; Martin F; Müller-Goymann C
Pharm Res; 2010 Aug; 27(8):1469-86. PubMed ID: 20411409
[TBL] [Abstract][Full Text] [Related]
15. Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process.
Elnaggar YS; El-Massik MA; Abdallah OY; Ebian AE
AAPS PharmSciTech; 2010 Jun; 11(2):645-51. PubMed ID: 20405257
[TBL] [Abstract][Full Text] [Related]
16. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
17. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
18. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
